Navigation Links
Kantar Health to Highlight Strategies for Accessing U.S. and EU Markets for Japan Pharma
Date:10/27/2013

New York NY (PRWEB) October 28, 2013

Kantar Health, a leading global healthcare consulting firm, and Synix will host a seminar, “The Keys to Market Access Success in the U.S. and European Markets,” on November 14 in Tokyo.

Changes in the healthcare system in the U.S. and Europe have a significant impact on the process of introducing new pharmaceutical agents, particularly high-cost specialty drugs such as oncolytics, to these markets. The importance of evaluating benefit assessments from the viewpoint of various stakeholders, such as patients, physicians and insurers, is rapidly rising. This seminar ? led by Gordon Gochenauer, Director, Commercial Planning (U.S.), and Andrew Miniuks, Senior Director, Commercial Planning (Europe) ? will cover:

  • U.S. and European Healthcare Systems: Do patients have access to the needed treatments and medications?
  • Pricing and Reimbursement: Will the drugs be reimbursed by insurance?
  • Stakeholder Relationships: How should pharmaceutical companies build relationships with stakeholders?
  • Case Studies in Oncology: Recent pricing, reimbursement and coverage decisions that highlight similarities and differences between the U.S. and Europe

The seminar will begin at 1 pm. Visit Synix’s website to register for this event (http://www.synix.co.jp/assessment/seminar/20131114/detail.html) or contact Gen Okamoto at market.assessment(at)synix(dot)co(dot)jp for more information.

About Kantar Health
Kantar Health is a leading global healthcare consulting firm and trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.

Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 700+ healthcare industry specialists work across the product lifecycle, from preclinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. For more information, please visit http://www.kantarhealth.com.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11270269.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Kantar Health to Highlight Role of Patient-Reported Outcomes in Russia
2. New Kantar Health Data Show Number of Newly Diagnosed Breast Cancer Patients in China Will Surpass U.S. by 2015
3. Biologic Treatment of Rheumatoid Arthritis Is Low in Brazil, According to Kantar Health Research
4. Treatment Rates of Prevalent Chronic Conditions Are Low in Brazil, According to Kantar Health Research
5. Kantar Health Americas CEO Mike Kelly Named to PharmaVOICE 100 for 2013
6. Kantar Health Launches CancerMPact Biomarker Analysis
7. Insulin Pump Therapy Provides Better Glycemic Control Among Type 1 Diabetics, According to Kantar Health Research
8. Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research
9. Kantar Health to Present at PBIRG Annual General Meeting
10. AACR honors Hagop Kantarjian for outstanding clinical research
11. Kantar Health to Participate in CIO Summit of America Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... May 25, 2016 , ... ... has seen a significant spike in their clients' employee participation for their wellness ... health screening by implementing a high-deductible health plan with outcome-based deductible incentives. As ...
(Date:5/25/2016)... ... , ... Stern Environmental Group , of Secaucus, New Jersey, working in ... Stern’s Real Time Monitoring (RTM) Device. Stern Environmental Group will sell the first ... for use in dormitories, shelters, and nursing homes for real time bedbug monitoring in ...
(Date:5/24/2016)... Milwaukee, WI (PRWEB) , ... May 24, 2016 ... ... has announced that Rudolfo (Rudy) Cifolelli has joined the company as Vice President ... and the development of U.S. and international sales in the rapidly expanding field ...
(Date:5/24/2016)... ... ... Jericho Project has named LaToya Williams-Belfort to the position of Chief Development and Communications ... the nationally-acclaimed nonprofit, working closely with CEO Tori Lyon and the Board of Directors ... , “LaToya Williams-Belfort is joining Jericho at an exciting time of growth and ...
(Date:5/24/2016)... ... 24, 2016 , ... How to Write Error Free Procedures, **Presented by Ginette ... Human error is known to be the major cause of quality and production losses ... eliminated, many human performance problems can be prevented. , How to Write Error Free ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... Non-invasive diagnostic test realizes the potential of ... be presented at Yissum’s booth, at IATI-BIOMED 2016 conference  ... the Hebrew University of Jerusalem announced today it ... MKI, the technology investment arm of Morris Kahn , ... early detection of multiple diseases by analyzing circulating DNA ...
(Date:5/23/2016)... May 23, 2016 Gamida Cell, ... treatment of cancer and orphan genetic diseases, announced today ... $4.4 million from the Israel Innovation Authority (formerly the ... of Economy and Industry. The mission of the Israel ... various industries, including science and technology, while stimulating economic ...
(Date:5/23/2016)... Conn. , May 23, 2016   ... has entered into an agreement with Egalet Corporation ... patent claims. As part of the agreement the ... and will enable all three companies to develop ... properties. "This agreement reflects the commitment ...
Breaking Medicine Technology: